These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 38059644)
1. Low-dose diazoxide is safe and effective in infants with transient hyperinsulinism. Malhotra N; Yau D; Cunjamalay A; Gunasekara B; S A; Gilbert C; Morgan K; Dattani M; Dastamani A Clin Endocrinol (Oxf); 2024 Feb; 100(2):132-137. PubMed ID: 38059644 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of Adverse Events in Children With Congenital Hyperinsulinism Treated With Diazoxide. Herrera A; Vajravelu ME; Givler S; Mitteer L; Avitabile CM; Lord K; De León DD J Clin Endocrinol Metab; 2018 Dec; 103(12):4365-4372. PubMed ID: 30247666 [TBL] [Abstract][Full Text] [Related]
3. Challenges in management of transient hyperinsulinism - a retrospective analysis of 36 severely affected children. Hoermann H; Roeper M; Salimi Dafsari R; Koestner F; Reinauer C; Mayatepek E; Meissner T; Kummer S J Pediatr Endocrinol Metab; 2021 Jul; 34(7):867-875. PubMed ID: 33860651 [TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of low-dose diazoxide in small-for-gestational-age infants with hyperinsulinaemic hypoglycaemia. Chandran S; R PR; Mei Chien C; Saffari SE; Rajadurai VS; Yap F Arch Dis Child Fetal Neonatal Ed; 2022 Jul; 107(4):359-363. PubMed ID: 34544689 [TBL] [Abstract][Full Text] [Related]
5. Necrotizing Enterocolitis in Neonates With Hyperinsulinemic Hypoglycemia Treated With Diazoxide. Keyes ML; Healy H; Sparger KA; Orth LE; Geha M; Roumiantsev S; Matute JD Pediatrics; 2021 Feb; 147(2):. PubMed ID: 33483452 [TBL] [Abstract][Full Text] [Related]
6. Higher C-peptide levels and glucose requirements may identify neonates with transient hyperinsulinism hypoglycemia who will benefit from diazoxide treatment. Davidov AS; Elkon-Tamir E; Haham A; Shefer G; Weintrob N; Oren A; Lebenthal Y; Mandel D; Eyal O Eur J Pediatr; 2020 Apr; 179(4):597-602. PubMed ID: 31863303 [TBL] [Abstract][Full Text] [Related]
7. Fetal Erythroblastosis May Be an Indicator of Neonatal Transient Hyperinsulinism. Mizumoto H; Iki Y; Yamashita S; Kawai M; Katayama T; Hata D Neonatology; 2015; 108(2):88-92. PubMed ID: 26044515 [TBL] [Abstract][Full Text] [Related]
8. Development of pulmonary hypertension in an infant treated with diazoxide. Nebesio TD; Hoover WC; Caldwell RL; Nitu ME; Eugster EA J Pediatr Endocrinol Metab; 2007 Aug; 20(8):939-44. PubMed ID: 17937066 [TBL] [Abstract][Full Text] [Related]
9. Paradoxical hypoglycaemia associated with diazoxide therapy for hyperinsulinaemic hypoglycaemia. Ponmani C; Gannon H; Hussain K; Senniappan S Horm Res Paediatr; 2013; 80(2):129-33. PubMed ID: 23886961 [TBL] [Abstract][Full Text] [Related]
11. Diazoxide-induced pulmonary hypertension in hyperinsulinaemic hypoglycaemia: Recommendations from a multicentre study in the United Kingdom. Chen SC; Dastamani A; Pintus D; Yau D; Aftab S; Bath L; Swinburne C; Hunter L; Giardini A; Christov G; Senniappan S; Banerjee I; Shaikh MG; Shah P Clin Endocrinol (Oxf); 2019 Dec; 91(6):770-775. PubMed ID: 31520536 [TBL] [Abstract][Full Text] [Related]
12. Cerebral Insufficiency Caused by Diazoxide in a Premature Neonate with Congenital Hyperinsulinism. Okada S; Fukunaga S; Ohta H; Furuta T; Hirano R; Motonaga T; Ishikawa Y Neuropediatrics; 2020 Jun; 51(3):211-214. PubMed ID: 31777044 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the duration of treatment with diazoxide in infants with prolonged hyperinsulinism (PHI). Raisingani M; Brar PC J Pediatr Endocrinol Metab; 2019 Nov; 32(11):1241-1245. PubMed ID: 31465295 [TBL] [Abstract][Full Text] [Related]
14. Rate of Serious Adverse Events Associated with Diazoxide Treatment of Patients with Hyperinsulinism. Thornton P; Truong L; Reynolds C; Hamby T; Nedrelow J Horm Res Paediatr; 2019; 91(1):25-32. PubMed ID: 30889588 [TBL] [Abstract][Full Text] [Related]
15. High prevalence of severe circulatory complications with diazoxide in premature infants. Yoshida K; Kawai M; Marumo C; Kanazawa H; Matsukura T; Kusuda S; Yorifuji T; Heike T Neonatology; 2014; 105(3):166-71. PubMed ID: 24458138 [TBL] [Abstract][Full Text] [Related]
16. Long-term treatment of persistent hyperinsulinaemic hypoglycaemia of infancy with diazoxide: a retrospective review of 77 cases and analysis of efficacy-predicting criteria. Touati G; Poggi-Travert F; Ogier de Baulny H; Rahier J; Brunelle F; Nihoul-Fekete C; Czernichow P; Saudubray JM Eur J Pediatr; 1998 Aug; 157(8):628-33. PubMed ID: 9727845 [TBL] [Abstract][Full Text] [Related]
17. Pulmonary Hypertension and Necrotizing Enterocolitis in Neonates Treated with Diazoxide. Duggal M; Moore SS; Simoneau J; Girard G; Gernet IB; Oettingen JEV; Sant'Anna G; Altit G Am J Perinatol; 2024 May; 41(S 01):e1435-e1444. PubMed ID: 36882098 [TBL] [Abstract][Full Text] [Related]
18. Delayed presentation of prolonged hyperinsulinaemic hypoglycaemia in a preterm small-for-gestational age neonate. Chong JH; Chandran S; Agarwal P; Rajadurai VS BMJ Case Rep; 2013 Dec; 2013():. PubMed ID: 24351577 [TBL] [Abstract][Full Text] [Related]
19. Randomised controlled trial of diazoxide for small for gestational age neonates with hyperinsulinaemic hypoglycaemia provided early hypoglycaemic control without adverse effects. Balachandran B; Mukhopadhyay K; Sachdeva N; Walia R; Attri SV Acta Paediatr; 2018 Jun; 107(6):990-995. PubMed ID: 29385640 [TBL] [Abstract][Full Text] [Related]